Bristol Myers Squibb (BMY)

SG&A Expense Growth

12.93%

Quarterly · Period ending:

BMY logo

BMY SG&A Expense Growth

Latest reported12.93%
BMY Quarterly SG&A Growth (QoQ) (0.00% → 12.93%)
High-resolution chart · PNG

BMY sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
12.9252%
-25.8597%
21.9117%
4.4367%
8.1439%
-25.8427%
7.7156%
2.8527%
-18.5467%
14.1823%
3.4948%
3.5677%
9.7616%
-22.2418%
17.4093%
8.0022%
-2.4031%
-22.2175%
31.6555%
-4.9947%
12.9652%
-38.7725%
59.4959%
4.7912%
1.3699%
-7.3818%
64.3602%
-1.9517%
6.9583%
-24.7006%
21.0145%
-2.3873%
15.4082%
-28.4672%
17.7988%
-2.0219%
9.4009%
-26.9852%
27.773%
-7.9177%
15.8716%
-29.6774%
26.634%
4.526%
10.8902%
-49.8099%
71.3355%
3.8039%
-0.0845%
-12.2313%
11.3955%
-11.0213%
15.0465%
-21.811%
21.9178%
1.0586%
2.6756%
-20.3198%
22.6307%
-5.3364%
13.2224%
-9.9369%
12.9118%
-2.9386%
4.0468%
50.4736%
-38.8751%
-3.125%
-0.399%
-29.0889%
12.5478%
-0.9464%
9.0847%
-17.0188%
21.3444%
-0.9609%
3.9971%
-18.9705%
17.2203%
-3.7834%
0%
-15.444%
10.8869%
0.1225%
8.7941%
-15.9104%
17.126%
-1.4867%
0.3243%
-9.8773%
15.3742%
-1.1992%
6.0777%
-5.1609%
17.2035%
-0.702%
9.4791%
-18.737%
21.5008%
-14.6763%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.